Company Filing History:
Years Active: 1989
Title: Eftihia Tzilianos: Innovator in Steroid Receptor Research
Introduction
Eftihia Tzilianos is a prominent inventor based in Astoria, NY (US). She has made significant contributions to the field of immunology, particularly in the development of innovative assays for steroid receptors. Her work has implications for both research and clinical applications.
Latest Patents
Eftihia Tzilianos holds a patent for "Auto-anti-idiotypic monoclonal antibodies to steroid receptors and uses." This invention describes a competitive immunoassay for steroid receptors, utilizing monoclonal antibodies that bind to the steroid receptor, which are then competitively bound by anti-steroid antibodies. The assay allows for the quantification of steroid receptors in biological samples, providing a valuable tool for researchers and clinicians alike. The patent outlines a detailed method for detecting and purifying steroid-receptor complexes, enhancing the understanding of steroid hormone interactions.
Career Highlights
Eftihia Tzilianos is affiliated with Columbia University, where she has contributed to various research initiatives. Her work has been recognized for its innovative approach to understanding steroid receptors and their biological significance. With a focus on developing practical applications for her research, she has established herself as a key figure in her field.
Collaborations
Throughout her career, Eftihia has collaborated with notable scientists, including Isidore S. Edelman and Bernard F. Erlanger. These collaborations have further enriched her research and expanded the impact of her inventions.
Conclusion
Eftihia Tzilianos is a trailblazer in the field of steroid receptor research, with her innovative patent contributing to advancements in immunoassays. Her work at Columbia University and collaborations with esteemed colleagues highlight her commitment to scientific progress. Eftihia's contributions continue to influence the landscape of immunology and steroid research.